Literature DB >> 31933453

Effects of different polyvinylpyrrolidone concentrations on intracytoplasmic sperm injection.

Ding Ding1,2,3, Qiushuang Wang1,2,3, Xinyuan Li1,4,5, Beili Chen1,4,5, Weiwei Zou1,4,5, Dongmei Ji1,4,5, Yan Hao1,4,5, Rufeng Xue1,4,5, Huijuan Zou1,4,5, Zhaolian Wei1,4,5, Ping Zhou1,4,5, Yunxia Cao1,4,5, Zhiguo Zhang1,2,3.   

Abstract

To explore whether different polyvinylpyrrolidone (PVP) concentrations affect the results of intracytoplasmic sperm injection (ICSI), a prospective study was conducted for 194 couples undergoing 210 ICSI therapy cycles. These cycles were divided into three groups (10, 7 and 5% groups) using the corresponding concentration of PVP for sperm immobilization. The main outcome measures were analyzed. Results indicated that, with a decrease in PVP concentrations, all of the main outcome measures increased. In particular, the high-quality cleavage embryo rate in the 7% group was significantly lower than in the 5% group (P < 0.01), and the cleavage, high-quality cleavage embryo, and high-quality blastocyst rates in the 5% group were significantly higher than those in the 10% group (all P < 0.001). For high-/intermediate-quality semen, all of the main outcome measures were significantly increased with 5% PVP. For the poor-quality semen, only the high-quality cleavage embryo and high-quality blastocyst rates were significantly higher in the 5% group. Therefore, lowering PVP concentrations greatly promoted the development of embryos in ICSI cycles, with an optimal concentration of 5% for ICSI.

Entities:  

Keywords:  Polyvinylpyrrolidone; concentration; development; intracytoplasmic sperm injection; semen

Year:  2020        PMID: 31933453     DOI: 10.1017/S0967199419000820

Source DB:  PubMed          Journal:  Zygote        ISSN: 0967-1994            Impact factor:   1.442


  5 in total

1.  Calcium chloride dihydrate supplementation at ICSI improves fertilization and pregnancy rates in patients with previous low fertilization: a retrospective paired treatment cycle study.

Authors:  Mark P Green; Deirdre Zander-Fox; Sophie Popkiss; Fabrizzio Horta; Beverley Vollenhoven
Journal:  J Assist Reprod Genet       Date:  2022-03-09       Impact factor: 3.357

2.  Application of Two Blastocyst Biopsy Strategies in Preimplantation Genetic Testing Treatment and Assessment of Their Effects.

Authors:  Han Yang; Dandan Yang; Qi Zhu; Kaijuan Wang; Chao Zhang; Beili Chen; Weiwei Zou; Yan Hao; Ding Ding; Zhaojuan Yu; Dongmei Ji; Dawei Chen; Yunxia Cao; Huijuan Zou; Zhiguo Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-04       Impact factor: 5.555

3.  Embryological Characteristics of Human Oocytes With Agar-Like Zona Pellucida and Its Clinical Treatment Strategy.

Authors:  Dandan Yang; Han Yang; Bo Yang; Kaijuan Wang; Qi Zhu; Jing Wang; Fangfang Ding; Bihua Rao; Rufeng Xue; Jing Peng; Qiushuang Wang; Yunxia Cao; Weiwei Zou; Beili Chen; Zhiguo Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

4.  Comparison of zeta potential and physiological intracytoplasmic sperm injection in obtaining sperms with a lower DNA fragmentation index: A cross-sectional study.

Authors:  Serajoddin Vahidi; Nima Narimani; Laleh Dehghan Marvast; Esmat Mangoli; Ali Nabi; Mohammad Sadeghi
Journal:  Int J Reprod Biomed       Date:  2022-06-08

5.  Identification of Novel Biallelic TLE6 Variants in Female Infertility With Preimplantation Embryonic Lethality.

Authors:  Manyu Zhang; Chunyu Liu; Beili Chen; Mingrong Lv; Huijuan Zou; Yajing Liu; Yang Gao; Tianjuan Wang; Qiong Xing; Yutong Zhu; Huan Wu; Zhiguo Zhang; Ping Zhou; Zhaolian Wei; Xiaojin He; Yuping Xu; Yunxia Cao
Journal:  Front Genet       Date:  2021-06-11       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.